Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Diabetes, Obesity & Metabolism|January 24, 2024
Postprandial glucose-management strategies in type 1 diabetes: Current approaches and prospects with precision medicine and artificial intelligenceAdnan Jafar, Melissa-Rosina Pasqua
Endocrinology, Diabetes & Metabolism Case Reports|January 27, 2025
Levothyroxine malabsorption following sleeve gastrectomyElodie Gruneisen, Ji Wei Yang, Melissa-Rosina Pasqua
Diabetes, Obesity & Metabolism|October 27, 2025
Changes to insulin requirements over time with semaglutide in adults with type 1 diabetes on insulin pump therapy: A post-hoc analysis of a double-blinded, randomised, crossover trialMelissa-Rosina Pasqua, Michael A Tsoukas, Ahmad Haidar
Journal of Diabetes Science and Technology|September 24, 2021
Strategically Playing with Fire: SGLT Inhibitors as Possible Adjunct to Closed-Loop Insulin TherapyMelissa-Rosina Pasqua, Michael A Tsoukas, Ahmad Haidar
Artificial Intelligence in Medicine|February 7, 2024
Advanced decision support system for individuals with diabetes on multiple daily injections therapy using reinforcement learning and nearest-neighbors: In-silico and clinical resultsAdnan Jafar, Melissa-Rosina Pasqua, Byron Olson, et al.
JCEM Case Reports|October 27, 2025
A Case of Insulin Edema Syndrome Improved by Weekly InsulinNoémie Desgagnés, Loredana Talos, Melissa-Rosina Pasqua, et al.
Journal of Diabetes Science and Technology|May 25, 2023
Participant Experiences of Low-Dose Empagliflozin Use as Adjunct Therapy to Hybrid Closed Loop: Findings From a Randomized Controlled TrialMelissa-Rosina Pasqua, Madison Odabassian, Michael A Tsoukas, et al.
Canadian Journal of Diabetes|November 1, 2025
Semaglutide Use With Automated Insulin Delivery in Adults With Type 1 Diabetes: Qualitative Analyses and Patient-reported Outcomes From a Randomized Controlled TrialMelissa-Rosina Pasqua, Joelle Doumat, Michael A Tsoukas, et al.
Diabetes Technology & Therapeutics|February 5, 2026
Continuous Ketone Monitoring Captures Overt Ketosis in Type 1 Diabetes Caused by Empagliflozin, Low-Carbohydrate Diet, and ExerciseElisabeth Lawton, Linden Perz, Melissa-Rosina Pasqua, et al.
Canadian Journal of Diabetes|September 8, 2022
Care Endpoints in Adults With Type 2 Diabetes: Screening and Therapeutic Targets at a Canadian Tertiary Diabetes Care CentreMelissa-Rosina Pasqua, Xiao Wen Hu, Vanessa Tardio, et al.
Pageof 2